Literature DB >> 10912458

Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat.

H M van der Velden1, J Ausma, M B Rook, A J Hellemons, T A van Veen, M A Allessie, H J Jongsma.   

Abstract

OBJECTIVE: It has been postulated that high atrial rate induced changes at the level of the gap junctions ('gap junctional remodeling', i.e. changes in distribution, intercellular orientation and expression of gap junction proteins), could be part of the vicious circle of electrophysiologic and structural changes leading to sustained atrial fibrillation (AF). To obtain experimental evidence in favour of such a postulate the timing of this remodeling process was studied in relation to the development of sustained AF in a goat model. METHODS AND
RESULTS: Thin sections from the left (LAA) and right atrial appendage (RAA) from goats in sinus rhythm (SR) or AF, induced through programmed endocardial burst pacing for time periods between 0 and 16 weeks, were immunolabeled with antibodies against connexin(Cx)40 and Cx43 and analysed by immunofluorescence and confocal laser scanning microscopy. During SR the distribution pattern for Cx43 was completely homogeneous (LAA and RAA) and for Cx40 mostly homogeneous (LAA: all five goats, RAA: three out of five goats). The distribution pattern for Cx43 remained stable during AF, while the Cx40 distribution pattern became increasingly heterogeneous, both in the LAA and RAA, with increasing duration of pacing. This increase in heterogeneity in Cx40 distribution correlated (Spearman rank order) with an increase in stability of AF and the occurrence of structural changes (myolysis) in atrial myocytes. The Cx40/Cx43 immunofluorescence signal ratio in both the LAA and RAA appeared to be significantly lower in AF (1-16 weeks) as compared to SR (0 weeks); going from 0 to 16 weeks average ratios decreased 54.5% (n=5; P=0.026) in the LAA and 35.8 (n=5; P=0.034) in the RAA. Western blot analyses revealed similar decreases in the total Cx40/Cx43 protein ratio, on average 50.0% (n=5; P=0.008) and 47.8% (n=5; P=0.02) in the LAA and RAA, respectively. No changes were measured in the levels of Cx40 or Cx43 mRNA, as was assessed through RT-PCR.
CONCLUSION: The time course of changes in the distribution and content of Cx40 gap junctions as observed during endocardial burst pacing of the goat atrium suggests that Cx40 gap junctional remodeling might be involved in the pathogenesis of sustained atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10912458     DOI: 10.1016/s0008-6363(00)00026-2

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  45 in total

Review 1.  Atrial fibrillation: basic mechanisms, remodeling and triggers.

Authors:  Akiko Shiroshita-Takeshita; Bianca J J M Brundel; Stanley Nattel
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

Review 2.  Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides.

Authors:  Stefan Dhein; Anja Hagen; Joanna Jozwiak; Anna Dietze; Jens Garbade; Markus Barten; Martin Kostelka; Friedrich-Wilhelm Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-27       Impact factor: 3.000

Review 3.  New insights into the mechanisms and management of atrial fibrillation.

Authors:  Paul Khairy; Stanley Nattel
Journal:  CMAJ       Date:  2002-10-29       Impact factor: 8.262

4.  The stress kinase JNK regulates gap junction Cx43 gene expression and promotes atrial fibrillation in the aged heart.

Authors:  Jiajie Yan; Justin K Thomson; Weiwei Zhao; Xiaomin Wu; Xianlong Gao; Dominic DeMarco; Wei Kong; Min Tong; Jun Sun; Mamdouh Bakhos; Vladimir G Fast; Qingrong Liang; Sumanth D Prabhu; Xun Ai
Journal:  J Mol Cell Cardiol       Date:  2017-11-13       Impact factor: 5.000

Review 5.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

6.  Association between connexin 40 and potassium voltage-gated channel subfamily A member 5 expression in the atrial myocytes of patients with atrial fibrillation.

Authors:  Fei Zhang; Yuhao Bian; Lei Huang; Wenbin Fan
Journal:  Exp Ther Med       Date:  2017-09-19       Impact factor: 2.447

7.  Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies.

Authors:  U Wetzel; A Boldt; J Lauschke; J Weigl; P Schirdewahn; A Dorszewski; N Doll; G Hindricks; S Dhein; H Kottkamp
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

Review 8.  Evolving concepts in the treatment of atrial fibrillation.

Authors:  Parimal B Maniar; Jonathan S Steinberg
Journal:  Curr Cardiol Rep       Date:  2003-09       Impact factor: 2.931

9.  A new role for extracellular Ca2+ in gap-junction remodeling: studies in humans and rats.

Authors:  S Dhein; N Duerrschmidt; A Scholl; A Boldt; J S Schulte; B Pfannmüller; D Rojas-Gomez; A Scheffler; J-A Haefliger; N Doll; F-W Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-16       Impact factor: 3.000

10.  In-silico modeling of atrial repolarization in normal and atrial fibrillation remodeled state.

Authors:  Martin W Krueger; Andreas Dorn; David U J Keller; Fredrik Holmqvist; Jonas Carlson; Pyotr G Platonov; Kawal S Rhode; Reza Razavi; Gunnar Seemann; Olaf Dössel
Journal:  Med Biol Eng Comput       Date:  2013-07-18       Impact factor: 2.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.